Volume 25, Number 8—August 2019
CME ACTIVITY - Synopsis
Zika Virus Infection in Pregnant Women, Yucatan, Mexico
Yamila Romer
, Nina Valadez-Gonzalez, Silvina Contreras-Capetillo, Pablo Manrique-Saide, Gonzalo Vazquez-Prokopec, and Norma Pavia-Ruz
, Nina Valadez-Gonzalez, Silvina Contreras-Capetillo, Pablo Manrique-Saide, Gonzalo Vazquez-Prokopec, and Norma Pavia-Ruz
Table 2
PCR results for pregnant women at time of first positive sample for Zika virus infection, Yucatan, Mexico
| Result | No. (%) |
|---|---|
| Zika virus positive at time of enrollment, n = 26 | |
| Blood and urine positive | 5 (19) |
| Blood positive, urine negative | 16 (61) |
| Blood positive without urine tested | 3 (11) |
| Urine positive without blood tested | 1 (4) |
| Blood negative, urine positive |
1 (4) |
| Zika virus positive during follow-up, n = 10 | |
| Blood and urine positive | 3 (30) |
| Blood positive, urine negative | 3 (30) |
| Blood positive without urine tested | 1 (10) |
| Urine positive without blood tested | 2 (20) |
| Blood negative, urine positive | 1 (10 |
| Total, n = 36 | 36 (100) |
| Blood and urine positive | 8 (22) |
| Blood positive, urine negative | 19 (53) |
| Blood positive without urine tested | 4 (11) |
| Urine positive without blood tested | 3 (8) |
| Blood negative, urine positive | 2 (6) |
Page created: July 15, 2019
Page updated: July 15, 2019
Page reviewed: July 15, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.